| Etiology and management of hypertension in patients with cancer T Mohammed, M Singh, JG Tiu, AS Kim Cardio-Oncology 7 (1), 14, 2021 | 55 | 2021 |
| Leptomeningeal Metastasis from Non–Small Cell Lung Cancer and Current Landscape of Treatments G Ozcan, M Singh, JJ Vredenburgh Clinical Cancer Research 29 (1), 11-29, 2023 | 43 | 2023 |
| A comprehensive review on cancer vaccines and vaccine strategies in hepatocellular carcinoma A Tojjari, A Saeed, M Singh, L Cavalcante, IH Sahin, A Saeed Vaccines 11 (8), 1357, 2023 | 14 | 2023 |
| A rare case of statin-induced immune-mediated necrotizing myopathy AS Madgula, NV Gadela, M Singh, K Chen Cureus 12 (4), 2020 | 9 | 2020 |
| Reversible ocular toxicity of oxaliplatin: a case report A Noor, A Desai, M Singh Cureus 11 (5), 2019 | 9 | 2019 |
| Etiology and management of dyslipidemia in patients with cancer M de Jesus, T Mohammed, M Singh, JG Tiu, AS Kim Frontiers in Cardiovascular Medicine 9, 892335, 2022 | 8 | 2022 |
| Bortezomib-induced motor neuropathy: A case report M Singh, VM Thomas, S Mulay Journal of Oncology Pharmacy Practice 26 (6), 1549-1552, 2020 | 6 | 2020 |
| Spontaneous tumor lysis syndrome due to endometrial carcinoma JJC Azanza, VM Thomas, PMC Sarmiento, M Singh, SA Alexander Cureus 12 (3), 2020 | 5 | 2020 |
| Ventricular tachycardia storm in a patient treated with ibrutinib for Waldenstrom macroglobulinemia AS Madgula, M Singh, M Almnajam, CC Pickett, AS Kim Cardio Oncology 2 (3), 523-526, 2020 | 4 | 2020 |
| Talaromycosis in a patient on nintedanib for interstitial lung disease AS Madgula, BR Covello, M Singh, A Rao, JC Lee Cureus 12 (3), 2020 | 3 | 2020 |
| Lung adenocarcinoma with metastasis to the vitreous–A case report and review of literature M Singh, VM Thomas, NL Lia, AS Madgula, I Putra, J Vredenburgh Current Problems in Cancer: Case Reports 3, 100064, 2021 | 2 | 2021 |
| CNS Metastasis and Ovarian Carcinoma. Is BRCA Mutation an Ally R Kulkarni A Case Report. Oncol Cancer Case Rep 7 (1), 001-003, 2021 | 2 | 2021 |
| Immune Checkpoint Inhibitors in Esophageal Carcinoma: Assessment of Efficacy Predictors of Response in Clinical Trials H Abushukair, A Abushukair, M Singh, A Saeed Surgical Oncology Clinics 33 (3), 583-593, 2024 | | 2024 |
| Who Should Receive Immunotherapy for Advanced Gastroesophageal Cancer? S Khateeb, L Cavalcante, N Alnairat, M Singh, IH Sahin, A Saeed, ... Current Treatment Options in Oncology, 1-14, 2024 | | 2024 |
| Inflammation gene signature to predict survival outcomes in hepatocellular carcinoma (HCC): A machine-learning approach. N Al-Bzour, IH Sahin, L Cavalcante, M Singh, AN Al-Bzour, A Saeed, ... Journal of Clinical Oncology 42 (3_suppl), 551-551, 2024 | | 2024 |
| Subject adherence: are the subjects following the protocol? If not, how to assess and analyze (intention to treat vs. per protocol) G Ozcan, M Singh, EM Mortensen Translational Radiation Oncology, 437-443, 2023 | | 2023 |
| Surveys and questionnaires: design, measures, and classical examples G Ozcan, M Singh, EM Mortensen Translational Radiation Oncology, 283-290, 2023 | | 2023 |
| Characterizing safety and efficacy in ovarian cancer patients with thromboembolism treated with rivaroxaban. CG Kohn, JT Caranfa, M Brewer, M Singh, CI Coleman, OS Costa Journal of Clinical Oncology 39 (15_suppl), e18720-e18720, 2021 | | 2021 |
| Descriptive cross-sectional analysis of lung cancer screening in inner city resident run clinic. M Singh, R Kulkarni, N Lopetegui-Lia, JJ Vredenburgh Journal of Clinical Oncology 39 (15_suppl), e18668-e18668, 2021 | | 2021 |
| Do differences in baseline clinical severity of ovarian cancer patients with thrombosis predict treatment with rivaroxaban versus low molecular-weight heparin? CG Kohn, JT Caranfa, M Brewer, M Singh, CI Coleman, OS Costa Journal of Clinical Oncology 39 (15_suppl), e18748-e18748, 2021 | | 2021 |
